Pharmacovigilance
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Types of Reports II: Incident or Occurrence Report
Healthcare Associated Infections II: Preventive Measures
Strategies for Assessing and Addressing Confounding
Relative Risk
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 19, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
David M Shahian1, Jeffrey P Jacobs2, Vinay Badhwar3
1Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Physician risk aversion stems from inadequate risk adjustment for high-risk patients. Optimizing data, models, and measures is key to mitigating this bias in performance reporting.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: